Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 11/2011

01-11-2011 | Research Articles

Fine-needle aspiration cytopathology in the diagnosis of Wilms tumor

Authors: Israel Fernández-Pineda, Rosa Cabello, Juan Antonio García-Cantón, Sonia Pérez-Bertolez, Íñigo Tuduri, Gema Ramírez, Catalina Márquez, Juan Carlos de Agustín

Published in: Clinical and Translational Oncology | Issue 11/2011

Login to get access
Metadata
Title
Fine-needle aspiration cytopathology in the diagnosis of Wilms tumor
Authors
Israel Fernández-Pineda
Rosa Cabello
Juan Antonio García-Cantón
Sonia Pérez-Bertolez
Íñigo Tuduri
Gema Ramírez
Catalina Márquez
Juan Carlos de Agustín
Publication date
01-11-2011
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 11/2011
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-011-0738-2

Other articles of this Issue 11/2011

Clinical and Translational Oncology 11/2011 Go to the issue

Educational Series / Green Series

Treatment for ALK-mutated non-small-cell lung cancer: a new miracle in the research race

Research Articles

Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: implications for patient outcome

Editorial

Antiangiogenic therapy of breast cancer. How did we get here? The road not taken

Educational Series / Blue Series

Heterogeneity of breast cancer: etiology and clinical relevance

Research Articles

Uncertainties and CTV to PTV margins quantitative assessment using cone-beam CT technique in clinical application for prostate, and head and neck irradiation tumours

Special Articles

Ameloblastoma, a rare benign odontogenic tumour: an interesting tumour review targeting the role of radiation therapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits